Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)
Site référencé: The Guardian (Asia Pacific)
3944.jpg?width=140&quality=85&auto=format&fit=max&s=3b43846a257ff075508ffce8a1f47d39, 3944.jpg?width=460&quality=85&auto=format&fit=max&s=7cc9fbebcd71e89831ebf650f0cbb809, 3944.jpg?width=700&quality=85&auto=format&fit=max&s=3205c77dea48b719949e7d6320e5d2ce
The Guardian (Asia Pacific)
The Guardian view on Euphoria : the show once pushed the envelope, but shock now seems to be the point | Editorial
2/06/2026
Ella Baron on the fallout from the latest Mandelson revelations – cartoon
2/06/2026
The BP drama will fade : boards are allowed to ditch the chair
2/06/2026
What’s missing from ‘embarrassing’ Mandelson files ? – The Latest
2/06/2026
New Danish government vows to resist Greenland pressure and tackle cost of living
2/06/2026
Everton interested in £15m Hayden Hackney but face stiff competition
2/06/2026